![](/img/cover-not-exists.png)
Survival analyses from the ZEBRA study: goserelin (Zoladex™) versus CMF in premenopausal women with node-positive breast cancer
M. Kaufmann, W. Jonat, R. Blamey, J. Cuzick, M. Namer, I. Fogelman, J.C. de Haes, M. Schumacher, W. SauerbreiVolume:
39
Year:
2003
Language:
english
DOI:
10.1016/s0959-8049(03)00392-7
File:
PDF, 265 KB
english, 2003